← Eichor
Study identifier: NCT07552116 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Low Intensity Laser Therapy on Immune System Response Among Children With Pneumonia

Condition: Pneumonia  ·  Sponsor: Badr University

PhaseNA
Planned participants40
Who can joinAll sexes, 3 Years to 5 Years
Healthy volunteersNo

About this study

Objective: The aim of this study was to detect the impact of low intensity laser therapy on immune system response among DS children with pneumonia. Material and Methods: Forty DS children with bronchopneumonia, were included into ; group (A) received low intensity laser therapy, inspiratory muscle training in addition to medical treatment at a frequency of 3 sessions per week for one month, where the second group (B) received inspiratory muscle training in addition to medical treatment. Measurements of WBCs, IgG, IgA, IgM, RR and SaO2 were obtained for both groups before treatment and after one month at the end of the treatment program.

This description comes directly from the study's public registry record.

Talk to the study team

Mona Mohamed Abdelkhalek, assistance professor  ·  00201024056108  ·  mona.abdelkhalek@buc.edu.eg

Mona Mohamed Abdelkhalek, assistance professor  ·  00201024056108  ·  3m.sons@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Mona Mohamed AbdelkhalekCairo, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07552116